This article summarizes the brief history of the biosimilars industry, the FDA’s regulations and guidance for biosimilars development, and the issues and challenges facing developers and regulators in bringing biosimilars to market.
Download the PDF White Paper: Biosimilars The Need, The Challenge, The Future The FDA Perspective Epstein, et al
